HANSA Celluxe PDRN Skin Booster packaging
Made in South Korea

HANSA Celluxe
PDRN Skin Booster

A clinical-grade regenerative skin booster developed by Korean biotech experts — trusted by aesthetic professionals across 12+ countries.

ISO 22716
GMP Certified
KFDA Approved
Formulation

Active Ingredients & Biological Mechanism

Each component is precision-selected for synergistic action at the cellular level.

01

Salmon DNA Extract

PDRN

Derived from wild salmon DNA, this highly bioactive ingredient stimulates cellular regeneration, tissue repair, and collagen synthesis to restore skin vitality at the dermal level.

02

Deep Hydration Complex

Hyaluronic Acid

Provides superior, long-lasting hydration and supports a plump, youthful complexion by maintaining moisture retention within the extracellular matrix.

03

Vitamin B3 Brightener

Niacinamide

A powerful brightening agent that reduces pigmentation and balances melanin production for a radiant, even skin tone with measurable luminosity improvement.

Clinical Outcomes

Proven Matrix Repair & Vitality

Five clinically validated outcomes that define the HANSA Celluxe standard of care.

  • 01

    Dermal Integrity Restoration

    Rebuilds the biological integrity of the dermis and epidermis to restore resilience and structural firmness.

  • 02

    Accelerated Wound Healing

    Accelerates the healing of wounds, acne scars, and damaged skin through targeted PDRN-driven tissue repair.

  • 03

    Anti-Inflammatory Action

    Soothes skin irritation and significantly reduces redness, calming reactive and sensitive skin conditions.

  • 04

    Lasting Hydration & Antioxidant Defense

    Provides intense hydration and antioxidant protection with clinically observed effects lasting 6–12 months.

  • 05

    Exceptional Biocompatibility

    Exceptional skin compatibility with no risk of adverse reactions, suitable for all skin types and tones.

HANSA Celluxe PDRN syringe — 2.5 mL single-use
Product Specification

HANSA Celluxe PDRN Syringe

A sterile, pre-filled 2.5 mL glass syringe containing a proprietary PDRN–Hyaluronic Acid–Niacinamide complex. Precision-engineered for subdermal injection at pH 6.0–8.0 with optimal viscosity for minimal tissue resistance and maximum bioavailability.

2.5 mLPer Syringe
3 ×Syringes / Kit
14 DaysTreatment Interval
Volume2.5 mL
UsageSingle-Use
pH Range6.0 – 8.0
Storage2°C – 25°C
SterilityUSP ‹71›
OriginSouth Korea
Indications

Target Areas & Skin Concerns

Versatile application across multiple anatomical zones and dermatological indications.

Treatment Areas

Full Face
Neck
Décolleté
Knees
Hands
Stretch Marks

Primary Concerns Addressed

Skin Laxity
Wrinkles
Fine Lines
Dark Eye Circles
Enlarged Pores
Dull Skin
Sensitive Skin
For Professionals

Professional Injection Protocols

Standardised clinical procedures developed for consistent, reproducible outcomes.

01

Face Protocol

5-Point Technique

2.5 mL total — 1 mL per side, 0.2 mL per injection point. Injected into the subdermal layer for optimal absorption.

Injection Points

  1. 01Zygomatic bone highest point
  2. 02Intersection of midpupillary and nasal wing lines
  3. 03Ear tragus
  4. 04Mental region (chin)
  5. 05Lower jaw nerve exit point
02

Neck Protocol

Preplatysmal Technique

2.5 mL total — 10 injection points distributed evenly across the neck area, 0.2 mL per point. Injected into the preplatysmal fat layer for targeted skin lifting and tightening.

Distribution Zones

  1. 01Upper neck — bilateral, 2 points per side
  2. 02Mid neck — bilateral, 2 points per side
  3. 03Lower neck — bilateral, 1 point per side
03

Treatment Course

Full Programme

A structured 3-session programme spaced 14 days apart, designed to maximise cumulative regenerative effect and long-term skin quality improvement.

Schedule

Sessions3 Total
IntervalEvery 14 Days
First ResultsWithin 24 Hours
AssessmentAfter 28 Days
Effect Duration6–12 Months
Quality Assurance

Regulatory Certifications

Every batch is manufactured under the strictest international quality standards. Click any certificate to view the official document.

Certificate of Free Sales

Korea Cosmetic Association · No. 2026-07542

Issued Mar 25, 2026 · Valid 2 years

View Document

Full Ingredient Formula

Official composition declaration

PDRN · Sodium Hyaluronate · Niacinamide

View Document

Biosafety Declaration

BSE / TSE Free · GMP Compliant

Issued Mar 30, 2026 · ZOE BIO Inc.

View Document

Bioburden & Stability Report

Sterility test · Accelerated stability

Korean Pharmacopoeia 12th Ed. · ISO 11737-1

View Document

Composition Certificate

Ingredient CAS numbers & concentrations

pH 6.0–8.0 · Volume ≥ 2.5 mL

View Document

Product Specification

Physicochemical quality criteria

Heavy metals · Viscosity · Purity limits

View Document

Sterilization Validation Report

USP <71> · BS EN ISO 11737-1

Issued Mar 30, 2026 · All samples passed

View Document

Declaration of Conformity

GMP ISO 22716:2007 · CMR-free

Issued Mar 20, 2026 · CEO signed

View Document

Biological Safety Statement

BSE / TSE free confirmation

No animal derivatives · No contaminants

View Document

ISO 22716 Certification

Good Manufacturing Practice

International GMP standard · ZOE BIO Inc.

View Document

Technical Data Sheet

Physical & chemical properties

pH 6.0–8.0 · Non-flammable · Water-soluble

View Document

Certificate of Free Sales

Korea Cosmetic Association · No. 2026-07542

Issued Mar 25, 2026 · Valid 2 years

View Document

Full Ingredient Formula

Official composition declaration

PDRN · Sodium Hyaluronate · Niacinamide

View Document

Biosafety Declaration

BSE / TSE Free · GMP Compliant

Issued Mar 30, 2026 · ZOE BIO Inc.

View Document

Bioburden & Stability Report

Sterility test · Accelerated stability

Korean Pharmacopoeia 12th Ed. · ISO 11737-1

View Document

Composition Certificate

Ingredient CAS numbers & concentrations

pH 6.0–8.0 · Volume ≥ 2.5 mL

View Document

Product Specification

Physicochemical quality criteria

Heavy metals · Viscosity · Purity limits

View Document

Sterilization Validation Report

USP <71> · BS EN ISO 11737-1

Issued Mar 30, 2026 · All samples passed

View Document

Declaration of Conformity

GMP ISO 22716:2007 · CMR-free

Issued Mar 20, 2026 · CEO signed

View Document

Biological Safety Statement

BSE / TSE free confirmation

No animal derivatives · No contaminants

View Document

ISO 22716 Certification

Good Manufacturing Practice

International GMP standard · ZOE BIO Inc.

View Document

Technical Data Sheet

Physical & chemical properties

pH 6.0–8.0 · Non-flammable · Water-soluble

View Document

Hover to pause · Click any card to open the official document